Increased nanoparticle-loaded exogenous macrophage migration into the brain following PDT-induced blood-brain barrier disruption

Lasers in Surgery and Medicine

Volumn 45, Issue 8, 2013, Pages 524-532

  Madsen, Steen J ^a   Gach, H Michael ^b   Hong, Seok Jin ^c   Uzal, Francisco A ^d   Peng, Qian ^e   Hirschberg, Henry ^f  

^a UNIVERSITY OF NEVADA   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

glioma; iron oxide nanoparticles; magnetic resonance imaging; photodynamic therapy

Indexed keywords

ALUMINUM PHTHALOCYANINE DISULFONATE; PHOTOSENSITIZING AGENT; SUPERPARAMAGNETIC IRON OXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN REGION; CONTROLLED STUDY; EDEMA; HISTOPATHOLOGY; INTRAVENOUS CATHETER; IRRADIATION; MACROPHAGE MIGRATION; MALE; MEMBRANE DAMAGE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PERLS STAINING; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RAT; STAINING;

GLIOMA; IRON OXIDE NANOPARTICLES; MAGNETIC RESONANCE IMAGING; PHOTODYNAMIC THERAPY;

ANIMALS; BLOOD-BRAIN BARRIER; CELL MIGRATION ASSAYS, MACROPHAGE; CONTRAST MEDIA; DEXTRANS; INDOLES; MACROPHAGES, ALVEOLAR; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; ORGANOMETALLIC COMPOUNDS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84884906073     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.22172     Document Type: Article

References (38)

1. Holdhoff M, Grossman SA,. Controversies in the adjuvant therapy of high-grade gliomas. Oncologist 2011; 16: 351-358.
2. Petrecca K, Guiot M-C, Panet-Raymond V, Souhami L,. Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma. J Neurooncol 2013; 111: 19-23.
3. Sathornsumetee S, Rich JN,. Designer therapies for glioblastoma multiforme. Ann NY Acad Sci 2008; 42: 108-132.
4. Knowles HJ, Harris AL,. Macrophages and the hypoxic tumour microenvironment. Front Biosci 2007; 12: 4298-4314.
5. Murdoch C, Lewis CE,. Macrophage migration and gene expression in response to tumor hypoxia. Int J Cancer 2005; 117: 701-708.
6. Fleige G, Nolte C, Synowitz M, Seeberger F, Kettenmann H, Zimmer C,. Magnetic labeling of activated microglia in experimental gliomas. Neoplasia 2001; 3: 489-499.
7. Jackson H, Muhammad O, Daneshvar H, Nelms J, Popescu A, Vogelbaum MA, Burchez M, Toms SA,. Quantum dots are phagocytized by macrophages and colocalize with experimental gliomas. Neurosurgery 2007; 60: 524-529.
8. Kennedy BC, Maier LM, D'Amico R, Mandigo CE, Fontana EJ, Waziri A, Assanah MC, Canoll P, Anderson RC, Anderson DE, Bruce JN,. Dynamics of central and peripheral immunomodulation in a murine glioma model. BMC Immunol 2009; 10: 11.
9. VanHandel M, Alizadeh D, Zhang L, Kateb B, Bronikowski M, Manohara H, Badie B,. Selective uptake of multi-walled carbon nanotubes by tumor macrophages in a murine glioma model. J Neuroimmunol 2009; 208: 3-39.
10. Hoelzinger DB, Demuth T, Berens ME,. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J Natl Cancer Inst 2007; 99: 1583-1593.
11. Hirschberg H, Baek S-K, Kwon YJ, Sun C-H, Madsen SJ,. Bypassing the blood brain barrier: Delivery of therapeutic agents by macrophages. Proc SPIE 2010; 7548: 3Z-1-5.
12. Madsen SJ, Baek S-K, Makkouk AR, Krasieva T, Hirschberg H,. Macrophages as cell-based delivery systems for nanoshells in photothermal therapy. Ann Biomed Eng 2012; 40: 507-515.
13. Hirschberg H, Uzal FA, Chighvinadze D, Zhang MJ, Peng Q, Madsen SJ,. Disruption of the blood-brain barrier following ALA-mediated photodynamic therapy. Lasers Surg Med 2008; 40: 535-542.
14. Hirschberg H, Zhang MJ, Gach HM, Uzal FA, Peng Q, Sun C-H, Chighvinadze D, Madsen SJ,. Targeted delivery of bleomycin to the brain using photo-chemical internalization of Clostridium perfringens epsilon prototoxin. J Neurooncol 2009; 95: 317-329.
15. Mathews MS, Chighvinadze D, Gach HM, Uzal FA, Madsen SJ, Hirschberg H,. Cerebral edema following photodynamic therapy using endogenous and exogenous photosensitizers in normal brain. Lasers Surg Med 2011; 43: 892-900.
16. Wu J, Yang S, Luo H, Zeng L, Ye L, Lu Y,. Quantitative evaluation of monocyte transmigration into the brain following chemical opening of the blood-brain barrier in mice. Brain Res 2006; 1098: 79-85.
17. Maman N, Dhami S, Phillips D, Brault D,. Kinetic and equilibrium studies of incorporation of di-sulfonated aluminum phthalocyanine into unilamellar vesicles. Biochim Biosphys Acta Biomebr 1999; 1420: 168-178.
18. Metz S, Bonaterra G, Rudelius M, Settles M, Rummeny EJ, Daldrup-Link HE,. Capacity of human monocytes to phagocytose approved iron oxide contrast agents in vitro. Eur Radiol 2004; 14: 1851-1858.
19. Oude Engberink RD, Blezer EL, Hoff EI, van der Pol SM, van der Toorn A, Dijkhuizen RM, de Vries HE,. MRI of monocyte infiltration in an animal model of neuroinflammation using SPIO-labeled monocytes or free USPIO. J Cereb Blood Flow Metab 2008; 28: 841-851.
20. Valable S, Barbier EL, Bernaudin M, Roussel S, Segebarth C, Petit E,. Remy C in vivo MRI tracking of exogenous monocytes/macrophages targeting brain tumors in a rat model of glioma. Neuroimage 2008; 40: 973-983.
21. deBoer AG, Gaillard PJ,. Drug targeting to the brain. Annu Rev Pharmacol Tocicol 2007; 47: 323-355.
22. Pardridge WM,. Blood-brain barrier delivery. Drug Discov Today 2007; 12: 54-61.
23. Thorek DL, Chen AK, Czupryna J, Tsourkas A,. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng 2006; 4: 23-38.
24. Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J,. Superparamagnetic iron oxide: Pharmacokinetics and toxicity. Am J Roentgenol 1989; 152: 167-173.
25. Weinstein JS, Varallyay CG, Dosa E, Gahramanov S, Hamilton B, Rooney WD, Muldoon LL, Neuwelt EA,. Superparamagnetic iron oxide nanoparticles: Diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J Cereb Blood Flow Metab 2010; 30: 15-35.
26. Madsen SJ, Sun C-H, Tromberg BJ, Hirschberg H,. Development of a novel indwelling balloon applicator for optimizing light delivery in photodynamic therapy. Lasers Surg Med 2001; 29: 406-412.
27. Angell-Petersen E, Hirschberg H, Madsen SJ,. Determination of fluence rate and temperature distributions in the rat brain; implications for photodynamic therapy. J Biomed Opt 2007; 12: 0140031-9.
28. Madsen SJ, Wilson BC,. Optical properties of brain tissue. In, Madsen SJ, editor. Optical methods and instrumentation in brain imaging and therapy. New York: Springer; 2013. pp 1-22.
29. Madsen SJ, Hirschberg H,. Site-specific opening of the blood-brain barrier. J Biophoton 2010; 3: 356-367.
30. Kinoshita M, McDannold N, Jolesz FA, Hynynen K,. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound. Biochem Biophys Res Commun 2006; 340: 1085-1090.
31. Kinoshita M, McDannold N, Jolesz FA, Hynynen K,. Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption. Proc Natl Acad Sci USA 2006; 103: 11719-11723.
32. Treat LH, McDannold N, Vykhodtseva N, Zhang Y, Tam K, Hynynen K,. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int J Cancer 2007; 121: 901-907.
33. Etame AB, Diaz RJ, O'Reilly MA, Smith CA, Mainprize TG, Hynynen K, Rutka JT,. Enhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasound. Nanomedicine 2012; 8: 1133-1142.
34. Vykhodtseva N, McDannold N, Hynynen K,. Progress and problems in the application of focused ultrasound for blood-brain barrier disruption. Ultrasonics 2008; 48: 279-296.
35. Sporn LA, Foster TH,. Photofrin and light induces microtubule depolymerization in cultured human endothelial cells. Cancer Res 1992; 52: 3443-3448.
36. Fingar VH,. Vascular effects of photodynamic therapy. J Clin Laser Med Surg 1996; 14: 323-328.
37. Baek S-K, Makkouk AR, Krasieva T, Sun C-H, Madsen SJ, Hirschberg H,. Photothermal treatment of glioma: An in vitro study of macrophage-mediated delivery of gold nanoshells. J Neurooncol 2011; 104: 439-448.
38. Wilson BC, Patterson MS,. The physics, biophysics and technology of photodynamic therapy. Phys Med Biol 2008; 53: R61-R109.